- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06534281
Pilot Study of BAO-G Technique in TAAA Endovascular Repair
August 1, 2024 updated by: Liu Bao, Peking Union Medical College Hospital
Pilot Study of Multi-Branch AOrtic Reconstruction With G-iliac System (BAO-G) Technique in Thoracoabdominal Aortic Aneurysm Endovascular Repair
Multi-Branch AOrtic Reconstruction With G-iliac System (BAO-G) Technique is a novel technique of endovascular repair of thoracoabdominal aortic aneurysm, which using off-the-shelf iliac branched devices to reconstruct the visceral branches.
This study aims to evaluate the safety and efficacy of BAO-G in thoracoabdominal aortic aneurysm endovascular repair.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China, 100730
- Peking Union Medical College Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with TAAA, confirmed by aortic CTA.
- TAAA diameter ≥ 6cm, or symptomatic TAAA with diameter ≥ 4cm.
- Informed consent signed.
Exclusion Criteria:
- were pregnant.
- had a history of previous endovascular or open repair.
- had other contraindications of endovascular treatment.
- Uncontrolled autoimmune disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: BAO-G group
|
Using G-iliac system to reconstruct the visceral branches of in endovascular repair of thoracoabdominal aortic aneurysm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of visceral branch patency
Time Frame: Month 0, 3, 6, 12, and annually after surgery
|
the patency of visceral branches measured by radiological test
|
Month 0, 3, 6, 12, and annually after surgery
|
|
Incidence of endoleak
Time Frame: Month 0, 3, 6, 12, and annually after surgery
|
The incidence of endoleak measured by radiological test
|
Month 0, 3, 6, 12, and annually after surgery
|
|
Incidence of re-operation
Time Frame: Month 0, 3, 6, 12, and annually after surgery
|
The incidence of re-operation for any adverse events, confirmed by medical record and outpatient follow up
|
Month 0, 3, 6, 12, and annually after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of organ ischemia
Time Frame: Month 0, 3, 6, 12, and annually after surgery
|
Incidence of organ ischemia, measured by physical examination and radiological test
|
Month 0, 3, 6, 12, and annually after surgery
|
|
Incidence of acute kidney injury
Time Frame: perioperative period
|
The incidence of acute kidney injury, measured by serum creatinine level
|
perioperative period
|
|
Incidence of acute liver function injury
Time Frame: perioperative period
|
The incidence of acute liver function injury, measured by serum transaminase level
|
perioperative period
|
|
Incidence of acute pancreatitis
Time Frame: perioperative period
|
The incidence of acute pancreatitis, measured by serum amylase level
|
perioperative period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2022
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2035
Study Registration Dates
First Submitted
July 29, 2024
First Submitted That Met QC Criteria
August 1, 2024
First Posted (Actual)
August 2, 2024
Study Record Updates
Last Update Posted (Actual)
August 2, 2024
Last Update Submitted That Met QC Criteria
August 1, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BAO-G-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Aneurysm, Thoracoabdominal
-
The Christ HospitalMedtronicRecruiting
-
W.L.Gore & AssociatesCMIC Co, Ltd. JapanRecruitingThoracoabdominal Aortic Aneurysm | Pararenal Aortic AneurysmJapan
-
University of South FloridaMedtronic; Sanford HealthActive, not recruiting
-
Peking Union Medical College HospitalChanghai Hospital; Fudan University; First Affiliated Hospital, Sun Yat-Sen University and other collaboratorsRecruitingThoracoabdominal Aortic Aneurysm | Complex Aortic Aneurysms | Endovascular RepairChina
-
Beijing Anzhen HospitalXiangya Hospital of Central South University; Guangzhou First People's Hospital and other collaboratorsRecruitingCardiopulmonary Bypass | Thoracoabdominal Aortic Aneurysm | Open RepairChina
-
Lifetech Scientific (Shenzhen) Co., Ltd.RecruitingThoracoabdominal Aortic AneurysmsChina
-
NYU Langone HealthCompletedThoracoabdominal Aortic AneurysmsUnited States
-
Lifetech Scientific (Shenzhen) Co., Ltd.RecruitingThoracoabdominal Aortic AneurysmsGermany
-
Sanford HealthDakota VascularActive, not recruitingThoracoabdominal AneurysmsUnited States
-
University of WashingtonRecruitingThoracoabdominal Aortic Aneurysm, Without RuptureUnited States
Clinical Trials on BAO-G
-
Peking Union Medical College HospitalChanghai Hospital; Fudan University; First Affiliated Hospital, Sun Yat-Sen University and other collaboratorsRecruitingThoracoabdominal Aortic Aneurysm | Complex Aortic Aneurysms | Endovascular RepairChina
-
FibroGenCompleted
-
Kaohsiung Medical University Chung-Ho Memorial...Not yet recruitingSleep Quality | Colorectal Cancer (CRC) | Chemotherapy Induced Peripheral Neuropathy (CIPN) | Quality of Life (QOL)Taiwan
-
Evofem Inc.Johns Hopkins University; MetroHealth Medical Center; Clinical Research Management...Completed
-
University of AarhusArla Foods; Mejeribrugets ForskningsFond; Innovation foundationCompletedProtein MetabolismDenmark
-
Clinical Nutrition Research Center, Illinois Institute...Completed
-
Boston Scientific CorporationCompletedPancreatic Cystic LesionsUnited States, China, India
-
Epeius BiotechnologiesTerminatedPancreatic CancerUnited States
-
Oslo Metropolitan UniversityUniversity of Oslo; Nofima; Mills DACompletedGut Microbiota | Satiety | Post Prandial Blood GlucoseNorway
-
King Faisal Specialist Hospital & Research CenterCompletedTransplantation for Hematologic MalignanciesSaudi Arabia